Fact-checked by Grok 2 weeks ago

Prostatic utricle

The prostatic utricle is a small, blind-ending of the , measuring approximately 6 mm in length, that projects upward and backward into the substance of the prostate gland behind its middle lobe. It is located at the apex of the verumontanum () along the posterior midline of the urethral crest, between the openings of the ejaculatory ducts. As a vestigial remnant of the paramesonephric (Müllerian) ducts, it arises embryologically from the incomplete regression of these structures in male development, influenced by factors such as testosterone and Müllerian inhibiting substance, and is homologous to the and upper in females. Structurally, the prostatic utricle is lined by and supported by walls composed of fibrous tissue, fibers, and numerous small glands that open into its , forming a slit-like on the urethral . It resides within the transition zone of the , which comprises about 5-10% of the glandular tissue in young adults, and is surrounded posteriorly by the central zone. While typically asymptomatic and incidental in most males, an enlarged prostatic utricle can manifest clinically, particularly in association with congenital anomalies like (with incidence rates of 11-27.5% depending on severity), leading to complications such as urinary tract infections, epididymo-orchitis, incontinence, or . Diagnosis often involves imaging modalities like ultrasonography, , or micturating cystourethrography, with treatment options ranging from to surgical interventions like endoscopic fulguration or laparoscopic excision for symptomatic cases.

Anatomy

Macroscopic anatomy

The prostatic utricle is a small, blind-ending pouch situated in the posterior wall of the , opening via a slit-like at the of the , also known as the verumontanum. It projects upward and backward into the substance of the prostate gland, behind the middle lobe, and is positioned between the openings of the ejaculatory ducts along the posterior midline of the urethral crest. This structure forms a cul-de-sac with no direct communication to the exterior except through its urethral opening. In adults, the prostatic utricle typically measures approximately 6 mm in length. It exhibits variations in size, with normal forms remaining small and inconspicuous, while enlarged variants—sometimes termed utriculus masculinus—can extend beyond this dimension and are classified based on length relative to the bladder neck or urethral position. Enlargement is often defined as allowing insertion of a 9 Fr (3 mm) cystoscope to a depth greater than 6 mm, with grades ranging from 0.5–1 cm (grade 0) to more than 2 cm where the dome extends over the bladder neck (grade II) or the opening shifts to the bulbar urethra (grade III). On , the prostatic utricle appears as a midline . reveals it as a slit-like at the verumontanum apex, potentially allowing visualization of the blind-ending pouch if enlarged. (MRI) depicts it as a high-signal-intensity midline cystic structure posterior to the , typically smaller than 10 mm and confined within the without extending above its upper border. shows it as a well-defined midline cystic in the male , often less than 10 mm, which may appear heterogeneous if containing debris such as in complicated cases.

Microscopic anatomy

The prostatic utricle is lined by (urothelium), akin to that of the , featuring ciliated cells and secretory cells that contribute to mucosal protection and potential lubrication. This epithelial layer rests on a and is supported by a containing . The wall of the prostatic utricle consists of a thin layer of fibers originating from the prostatic , providing limited contractile support. These muscle fibers are enveloped by fibroelastic , which offers structural flexibility and integration with the surrounding prostatic capsule. Innervation to the prostatic utricle arises from the prostatic plexus, incorporating sympathetic fibers from the for control and parasympathetic fibers from for secretory modulation. Its vascular supply derives from branches of the prostatic arteries, which are inferior vesical and middle rectal arteries, ensuring nutrient delivery through a rich network within the stromal layers.

Embryological development

Origin and formation

The prostatic utricle derives from the caudal remnant of the paramesonephric () ducts in embryos. These ducts, which initially form bilaterally around week 7 of gestation, fuse caudally and contact the by approximately week 9, but largely regress due to (AMH) secreted by Sertoli cells in the developing testes starting around week 8. This regression, typically complete by weeks 10-12, spares a small caudal portion that persists as the prostatic utricle, a vestigial structure. The formation of the prostatic utricle coincides with broader urogenital development between weeks 7 and 10, during which prostate buds emerge from the under the influence of signaling. By around week 18, the utricle becomes defined through the fusion of sino-utricular bulbs—derived from the —with the Müllerian tubercle, establishing its connection to the at the verumontanum. Testosterone, produced by fetal Leydig cells from week 9 onward, stabilizes the mesonephric (Wolffian) ducts and drives outgrowth, contrasting with AMH's role in Müllerian regression and indirectly shaping the utricle's position. The utricle forms at the junction where the regressed Müllerian ducts meet the , situated midline between the paired Wolffian ducts, from which the ejaculatory ducts arise distinctly as mesonephric derivatives. However, its origin remains disputed, with histological and immunohistochemical evidence indicating a composite nature involving partial endodermal contribution from the rather than a purely Müllerian (mesodermal/ectodermal) source; for instance, the utricle expresses basal markers like p63 from epithelium while showing variable or absent Müllerian-specific staining, such as Pax-2, in later fetal stages. This dual-origin hypothesis underscores the complex interplay of regression signals, with AMH and testosterone ensuring the utricle's vestigial persistence amid .

Persistence and remnants

The persistence of the prostatic utricle arises from the incomplete regression of the caudal segment of the Müllerian ducts during embryonic development in males. In typical male differentiation, (AMH), secreted by Sertoli cells, induces regression of the Müllerian ducts starting from the cranial portions, but the caudal ends fuse and partially incorporate into the , evading full AMH-mediated degeneration and forming the utricle. In disorders of sexual development (DSD) such as (PMDS), global defects in AMH or receptor (e.g., in AMH or AMHR2 genes) lead to more extensive remnants beyond the utricle, including uterine and vaginal structures. From a comparative embryological perspective, the prostatic utricle exemplifies partial in , where AMH ensures near-complete duct elimination except for this caudal remnant, whereas DSD conditions like PMDS demonstrate failed with retained fallopian tubes and alongside the utricle. This highlights the precision of hormonal signaling in , with the utricle serving as a consistent marker of the Müllerian site. Evolutionarily, the prostatic utricle represents a vestigial remnant of the Müllerian duct system, underscoring the shared embryonic origins of reproductive tracts from common anlagen, without any established adaptive function in modern human males. Autopsy studies confirm the prostatic utricle is present in nearly all males as a normal structure, though its prominence varies, with rudimentary forms predominant and enlarged variants (e.g., ≥10 mm) occurring in approximately 1% of cases, often linked to associated anomalies.

Function

Anatomical homology

The prostatic utricle represents the male homolog of the and upper , arising as the caudal remnant of the paramesonephric (Müllerian) ducts that merge during embryonic development. In females, these ducts fully differentiate into the and proximal , whereas in males, they regress under the influence of (AMH) secreted by Sertoli cells, leaving the utricle as a vestigial structure. This underscores the shared embryonic origins across sexes, with the utricle often referred to as the "uterus masculinus" to highlight its correspondence to the female uterine fundus. Structurally, the prostatic utricle shares key features with the female uterus, including its configuration as a blind-ending pouch lined by columnar capable of glandular development, akin to endometrial . This epithelial similarity allows for potential pathological changes, such as glandular proliferation or even rare neoplastic transformations mirroring those in the female reproductive tract. The pouch's midline location within the further parallels the uterine cavity's central positioning. Historically, this anatomical homology was recognized in early anatomical literature, with terms like "vagina masculina" and "uterus masculinus" coined in the 19th and early 20th centuries to describe the structure's resemblance to genitalia, as noted in foundational texts on urogenital . In , the utricle's vestigial nature in males contrasts sharply with its elaborate development in s, where the absence of AMH permits full . In the context of (DSD), an enlarged prostatic utricle can mimic female reproductive structures, particularly in males with conditions involving incomplete Müllerian duct regression, such as or severe . This enlargement, observed in approximately 40% of proximal cases, highlights the utricle's potential to retain Müllerian characteristics under altered hormonal influences.

Physiological role

The prostatic utricle is primarily a vestigial structure in adult males, representing a remnant of embryonic with no essential role in or urinary function. Its potential physiological contributions are minor and largely unproven, but early observations suggest rhythmic contractions during may assist in semen expulsion by influencing the proximity of openings. Cystoscopic examinations in the early , for instance, noted these contractions drawing the utricle toward the ducts to facilitate fluid passage during coitus. The utricle's walls include fibrous , smooth muscle fibers, and a lined with numerous small glands that open internally, providing limited secretory activity. In contrast to its female homologues, which support reproductive processes including some glandular secretion, the prostatic utricle exhibits no endocrine function, lacking any capacity for production or storage. Data on its activity in non-human species remain sparse, though comparative anatomical studies in , lagomorphs, and canines reveal consistent presence of muscular components in the utricle, implying possible synchronization of contractions with orgasmic reflexes akin to those in .

Clinical significance

Congenital variations

The prostatic utricle exhibits several congenital variations arising from incomplete regression of the Müllerian ducts during embryonic development. One prominent association is with , particularly proximal forms, where an enlarged utricle occurs in up to 70% of cases due to incomplete Müllerian regression. This enlargement is thought to result from shared developmental pathways affecting urethral and genital fold fusion. In (DSD), the prostatic utricle is frequently involved, notably in (PMDS), where bilateral remnants and a persist alongside an enlarged utricle. PMDS represents a of (AMH) action, leading to retention of Müllerian structures in genetically male individuals. Isolated enlargements of the prostatic utricle, termed utriculus masculinus, can occur without external genital anomalies, with an incidence of approximately 1-3% in boys evaluated for urological issues, and most cases remaining asymptomatic throughout life. These variations are often incidental findings during imaging or . Congenital variations are classified primarily by size and communication with adjacent structures using the Ikoma classification into four grades based on extent: Grade 0 (small, opening located at the posterior without extension beyond the verumontanum), Grade I (larger than Grade 0 but does not reach the bladder neck), Grade II (reaches the bladder neck), and Grade III (extends beyond the bladder neck toward the ), with higher grades correlating to severity. Regarding communication, utricles may be blind-ending or possess a narrow orifice to the ; some anomalous forms connect to the via persistent remnants, potentially altering flow. Genetic factors underlying these variations include rare mutations in the AMH gene (on ) or AMH receptor type II gene (AMHR2, on ), which impair Müllerian duct regression and predispose to utricle persistence, as seen in 85-90% of PMDS cases. These mutations follow an autosomal recessive pattern and are identifiable through genetic sequencing in affected families.

Symptomatic conditions and management

Symptomatic prostatic utricles, often enlarged cysts, can lead to a range of urinary and reproductive issues. Common symptoms include , recurrent urinary tract infections (UTIs), , , , incontinence, and . In some cases, patients present with abdominal masses, , or due to mass effect. Calculi formation within enlarged utricles may exacerbate symptoms by causing obstruction or chronic inflammation. Complications of symptomatic prostatic utricles include recurrent epididymo-orchitis, which can lead to potential renal impairment if untreated, and due to semen reflux or . and have been reported in association with obstructive cysts. is rare but documented, with reported cases of , urothelial , and clear cell arising in utricle cysts, occurring in up to 3% of cases. Diagnosis typically involves and endoscopic evaluation. Ultrasonography and MRI are used to assess size and location, while or retrograde urethrography evaluates for . remains the gold standard for visualization and confirmation of communication with the . Management begins with conservative approaches for mild symptoms, such as antibiotics for infections or for small cysts. For persistent symptoms, endoscopic treatments like transurethral resection, , or fulguration are initial options, though they carry higher recurrence risks. Surgical excision via , perineal approach, or open surgery is recommended for larger or recurrent cases, particularly when associated with repair. Risks of surgery include urethral injury, , and incontinence. Outcomes following surgical excision show high success rates, with symptom resolution in over 80% of cases and low recurrence when using open or laparoscopic methods. Long-term follow-up is essential to monitor fertility and prevent complications like recurrent infections. Recent advances include minimally invasive techniques such as laser ablation for deroofing and of calculi, demonstrating effective symptom relief with reduced morbidity in studies from 2020 onward.

References

  1. [1]
    Prostatic utricle - e-Anatomy - IMAIOS
    Its walls are composed of fibrous tissue, muscular fibers, and mucous membrane, and numerous small glands open on its inner surface.
  2. [2]
    Prostate Anatomy - Medscape Reference
    Feb 24, 2025 · A small midline pit, the prostatic utricle, is found at the apex of the seminal colliculus. On either side of the utricular orifice, small ...
  3. [3]
    Prostatic utricle | Radiology Reference Article - Radiopaedia.org
    Sep 2, 2020 · Prostatic utricle refers to Mullerian duct remnant in males which often manifests as a sac having a slit like orifice at the apex of verumontanum.
  4. [4]
    Symptomatic prostatic utricle: various approaches for treatment
    Dec 9, 2020 · Prostatic utricle arises from the prostate in the midline at proximal verumontanum level in between the ejaculatory ducts (Fig. 1). Although ...
  5. [5]
  6. [6]
    Newer Insights into Prostatic Utricle in Proximal Hypospadias - PMC
    Jul 26, 2022 · In effort to standardize the definition of enlarged PU, we considered any utricle in which a cystoscope of at least 9 Fr (3 mm) could be ...<|separator|>
  7. [7]
    Prostatic utricle cyst | Radiology Reference Article - Radiopaedia.org
    Oct 24, 2024 · Utricle cysts are variable in size but are usually smaller (commonly <10 mm) than Müllerian duct cysts and usually do not extend above the ...
  8. [8]
    Histology, Male Urethra - StatPearls - NCBI Bookshelf
    May 1, 2023 · The two commonly utilized histological stains to observe the male urethra are the hematoxylin and eosin stain and the trichrome stain.
  9. [9]
    Longitudinal Muscular Column in the Prostatic Urethral Wall - PubMed
    Results: At the proximal level of the prostate, the ejaculatory ducts (EDs) and prostatic utricle (PU) together were surrounded by circular smooth-muscle fibers ...
  10. [10]
    Anatomy & histology-prostate - Pathology Outlines
    Nov 20, 2023 · Prostatic urethra begins on superior surface, descends almost vertically, with continuous prostatic utricle extending to posterior prostatic wall, exits ...
  11. [11]
    Sexual Differentiation - Endotext - NCBI Bookshelf - NIH
    Jul 24, 2025 · Maturation of the prostatic gland is accompanied by development of the prostatic utricle. Two buds of epithelial cells, called the sino- ...
  12. [12]
    [PDF] JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
    The prostatic utricle is a composite of the urogenital sinus and the mullerian duct. Regression of the mullerian duct in males is controlled by AMH, which is ...
  13. [13]
    Development of the human prostate - PMC - PubMed Central - NIH
    This paper provides a detailed compilation of human prostatic development that includes human fetal prostatic gross anatomy, histology, and ontogeny
  14. [14]
    The prostatic utricle is not a Müllerian duct remnant - PubMed
    The embryological origin of the utricle is thought to be a remnant of the fused caudal ends of the müllerian ducts (MDs). Others propose that the urogenital ...
  15. [15]
    New theory of uterovaginal embryogenesis - PMC - NIH
    The prostatic utricle is believed to be a remnant of the fused caudal ends of the paramesonephral ducts.
  16. [16]
    Embryology, Mullerian-inhibiting Factor - StatPearls - NCBI Bookshelf
    Mullerian inhibiting factor (MIF), also called the anti-Mullerian hormone (AMH), plays a significant role in sexual differentiation.Missing: utricle | Show results with:utricle
  17. [17]
    Anti-Müllerian Hormone Signal Transduction involved in ... - Frontiers
    In the male vertebrate embryo, AMH is responsible for the regression of the Müllerian duct (MD), the anlagen of the uterus, Fallopian tubes, and upper part of ...
  18. [18]
    [PDF] The persistent Müllerian duct syndrome: an update based upon a ...
    Feb 10, 2020 · Male sex differentiation is driven by two hormones, testosterone and anti-Müllerian hormone (AMH), responsible for regression of Müllerian ...<|control11|><|separator|>
  19. [19]
    Participation of Caudal Müllerian Mesenchyma in Prostate ...
    In the prostate the prostatic utricle is a remnant of the caudal müllerian duct. Therefore, the prostatic utricle indicates the location of the caudal ...
  20. [20]
    Persistent Müllerian duct syndrome and enlarged prostatic utricle in ...
    Jul 4, 2023 · Utricular abnormalities have been commonly discovered in the incomplete regression of Müllerian duct cases or the incomplete closure of the ...
  21. [21]
    Cystoscopy to investigate the prevalence of prostatic utricle cyst in ...
    Feb 25, 2025 · Purpose: Prostatic utricle cyst (PUC) is known to be associated with hypospadias. We aimed to investigate the prevalence of PUC in children ...
  22. [22]
    Prevalence and Characteristics of Prostatic Utricles: A Retrospective ...
    Apr 28, 2025 · The average prostate size for patients with a utricle was 78.3 cc and the average utricle size was 0.4 cm3.Missing: dimensions adults
  23. [23]
    Insights into enlarged prostatic utricles and Müllerian duct ... - PubMed
    The prostatic utricle (PU) consists of the caudal remnant of the Müllerian duct and the urogenital sinus. The term "vagina masculina" is used if other Müllerian ...
  24. [24]
    Endometrial carcinoma of prostatic utricle (uterus masculinus)
    The utricle devel- ops from the paramesonephric, i.e. the mul- lerian ducts, and is thought by some to be homologous with the vagina of the female; therefore ...
  25. [25]
    Prostatic utricle – Knowledge and References - Taylor & Francis
    The prostatic utricle is a small, vestigial structure that is the homologue of the uterus and is a blind-ending sac. It is an embryonic remnant of Mullerian ...
  26. [26]
    Enlarged prostatic utricle and vagina masculinus in boys ... - PubMed
    Jan 2, 2023 · This study shows that the prevalence of enlarged prostatic utricles and vagina masculinus is high in patients with severe hypospadias.
  27. [27]
    Insights into enlarged prostatic utricles and Müllerian duct system ...
    The incidence of enlarged PUs increases with severe 'posterior' hypospadias or disorders of sexual differentiation (DSD) cases [2]. Enlarged utricles are ...
  28. [28]
    Utricular Cyst (Prostatic Utricular Cyst) - SpringerLink
    Nov 8, 2016 · In 1905, Robert William Taylor stated the function of the prostatic utricle thusly: “In coitus it so contracts that it draws upon the ...
  29. [29]
    Comparative Study of Prostatic Utricle in Rat, Rabbit, Dog and Man
    The prostatic utricle is one of the auxiliary glands associated with the genital duct systems in males. In man it is described as a blind pouch about 6mm long.
  30. [30]
    Newer Insights into Prostatic Utricle in Proximal Hypospadias
    Jul 26, 2022 · Enlarged symptomatic utricles are known to be associated with hypospadias. ... Enlarged utricle was found in 47/70 (67.14%) on cystoscopy. They ...
  31. [31]
    Prevalence and Characteristics of Prostatic Utricles: A Retrospective ...
    Apr 28, 2025 · Prostatic utricle is an enlarged diverticulum in the posterior urethra, which results from incomplete degradation of the Müllerian ducts or ...
  32. [32]
    Prostatic utricles without external genital anomalies in children - NIH
    Apr 3, 2019 · The prostatic utricle is an enlarged diverticulum in the posterior urethra, which result from incomplete degradation of the Müllerian ducts or ...
  33. [33]
    Classification of enlarged prostatic utricle in patients with hypospadias.
    A direct relationship was demonstrated between the severity of hypospadias and increasing size of the prostatic utricle. An enlarged prostatic utricle is ...
  34. [34]
    A case series on persistent Mullerian duct syndrome
    In 85% of patients with PMDS, a failure to produce functional AMH due to a mutation of AMH gene (45%) on chromosome 19 or a defective type II AMH receptor due ...
  35. [35]
    Prostatic Utricle Cyst: A Clinical Dilemma - PMC - NIH
    May 10, 2013 · Prostatic utricle cyst is a rare midline cystic lesion between the urinary bladder and the rectum, commonly associated with hypospadias.
  36. [36]
    Successful treatment of seminal vesicle calculi and prostatic utricle ...
    Aug 26, 2020 · In our study, the intraoperative holmium laser energy did not exceed 10 W, which is consistent with a previous report (Zhang et al., 2017).
  37. [37]
    Urothelial carcinoma within the prostatic utricle of an adult with ... - NIH
    Oct 15, 2019 · Reported malignancies in the prostatic utricle include urothelial carcinoma, clear cell adenocarcinoma, endometrial carcinoma, and squamous cell ...
  38. [38]
    Robotic management of a large mullerian duct cyst: a case report ...
    Sep 27, 2022 · The trial performed by Coppens et al. of 17 cases showed a success rate of 82% in patients with small, uncomplicated cysts that initially ...
  39. [39]
    Transurethral ablation of prostatic utricle cyst using holmium laser
    The purpose of this video is to demonstrate a safe and effective approach to the treatment of obstructing midline prostate utricle cyst using holmium laser.Missing: advances | Show results with:advances